Anebulo Pharmaceuticals Board Approves Reverse Stock Split
Anebulo Pharmaceuticals Inc. announced its Board's approval of a proposed reverse stock split of common stock, pending stockholder approval at a future special meeting. The meeting date is yet to be determined, and the Board is reviewing strategic alternatives. This AI-generated news is for informational purposes and not financial advice. Original content was published via EDGAR by Anebulo Pharmaceuticals.
Anebulo Pharmaceuticals Inc. has announced that its Board of Directors has approved a proposed reverse stock split of the company’s common stock, pending approval by stockholders at a future special meeting. The date of the meeting has not yet been determined, and the Board is continuing to review all strategic alternatives available to the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anebulo Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-022310), on November 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
